1. Home
  2. LIXT vs PMEC Comparison

LIXT vs PMEC Comparison

Compare LIXT & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$5.35

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo Primech Holdings Ltd.

PMEC

Primech Holdings Ltd.

HOLD

Current Price

$0.74

Market Cap

26.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
PMEC
Founded
2005
1984
Country
United States
Singapore
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
26.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LIXT
PMEC
Price
$5.35
$0.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.5K
303.7K
Earning Date
05-08-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.52
52 Week High
$6.09
$2.44

Technical Indicators

Market Signals
Indicator
LIXT
PMEC
Relative Strength Index (RSI) 67.95 52.47
Support Level $3.77 $0.61
Resistance Level $6.03 $0.81
Average True Range (ATR) 0.63 0.08
MACD 0.05 0.01
Stochastic Oscillator 82.72 57.32

Price Performance

Historical Comparison
LIXT
PMEC

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Share on Social Networks: